Sun Pharma profit halves, chief moved amid scandal
Bloomberg Sun Pharmaceutical Industries Ltd’s fourth-quarter profit halved from a year ago as the fallout from a corporate governance scandal caused it to take a 10.85 billion-rupee charge ($155.7 million) and led to the brother-in-law of billionaire founder Dilip Shanghvi moving to a non-executive role. Shares rose by as much as 2 percent on Wednesday morning trading as investors cheered ...
Read More »